Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-27219

Xla Wt + Haldol [0.4-2.05 mg/l], Morais F et al. (2024)

Experiment + Assay: Xla Wt + Haldol [0.4-2.05 mg/l] + NF45-46 (whole-mount microscopy)
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical haloperidol
NF stage 45 whole organism
Conditions:
Assay Type Assay Stages Antibody
whole-mount microscopy NF stage 45 to NF stage 46  
Anatomical Phenotypes: decreased pigmentation in the whole organism, edematous embryo
Source: Fig. 5
Article: XB-ART-60877, PubMed